LoginSignup
Becton Dickinson logo

Becton Dickinson

Stock
Stock
Ticker: BDX
BDX

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Becton Dickinson has so far distributed $2.10 in 2026. The next dividend will be paid on 30.09.2026

$1.492

CHART BY

Frequently asked questions

The market capitalization of Becton Dickinson is $48.05B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Becton Dickinson is 53.21. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Becton Dickinson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.315. EPS indicates the company's profitability on a per-share basis.
Currently, 17 analysts cover Becton Dickinson's stock, with a consensus target price of $193.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Becton Dickinson reported a revenue of $20.84B.
Yes, Becton Dickinson is paying dividends. The next payment is scheduled for 30.09.2026, with an expected amount of .
Becton Dickinson's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $5.25B. EBITDA measures the company's overall financial performance.
Becton Dickinson has a free cash flow of $2.53B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Becton Dickinson employs approximately 72,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Becton Dickinson is 271.79M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$48.05B
EPS (TTM) 
$3.315
Free Float 
271.79M
P/E ratio (TTM) 
53.21
Revenue (TTM) 
$20.84B
EBITDA (TTM) 
$5.25B
Free Cashflow (TTM) 
$2.53B

Pricing

1D span
$176.28$178.17
52W span
$140.11$213.00

Analyst Ratings

The price target is $193.00 and the stock is covered by 17 analysts.

Buy

8

Hold

8

Sell

1

Information

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Employees
72,000
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
BDX

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin